Please Wait.....
Report
Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) - Global Forecast to 2029
Market Report I 2024-05-02 I 298 Pages I MarketsandMarkets
The global cardiac monitoring & cardiac rhythm management devices market is expected to reach USD 26.4 Billion by 2029 from USD 21.3 Billion in 2024, at a CAGR of 4.3% during the forecast period. Market is driven by factors such as rising public awareness campaigns and screening programs aimed at detecting cardiovascular diseases early contribute to the growing demand for cardiac monitoring devices, especially in high-risk populations. On the other hand, The adoption of remote monitoring and telemedicine technologies raises concerns about data security and patient privacy, which may hinder patient acceptance and adoption of these devices.
"The Implantable Cardioverter Defibrillators accounted for the largest market share in the Cardiac Rhythm Management Device market, during the forecast period"
Based on the type, Defibrillators in Cardiac Rhythm Management Devices Market is classified into Implantable Cardioverter Defibrillators, External Defibrillators. In 2023, Implantable Cardioverter Defibrillators accounted for a sizable market share because Implantable defibrillators provide continuous protection against sudden cardiac arrest by constantly monitoring the heart's rhythm and delivering appropriate therapy when needed. This continuous monitoring and intervention offer round-the-clock protection for patients at risk of life-threatening arrhythmias, whereas external defibrillators are typically used for acute interventions in emergency situations. Likewise, Implantable defibrillators are implanted surgically or via minimally invasive procedures in patients at high risk of sudden cardiac death due to underlying cardiac conditions such as ventricular arrhythmias or cardiomyopathy. They are intended for long-term use and are suitable for patients who require ongoing arrhythmia management. In contrast, external defibrillators, such as automated external defibrillators (AEDs) or manual defibrillators used in hospitals, are primarily used for emergency resuscitation in cases of cardiac arrest.
"Patient Activated technology segment accounted for the largest market share"
Based on technology, the Event monitor's in cardiac monitoring devices market is segmented into -Patient Activated, Auto Detected. The Patient Activated technology segment accounted for the largest market share in 2023., due to its variety of applications such as, Patient-activated event monitors require the active participation of the patient, who triggers the recording of an event when they experience symptoms such as palpitations or dizziness. This level of patient engagement can lead to higher compliance with monitoring protocols and more reliable data collection compared to auto-detected monitors, which may miss transient or asymptomatic events. Moreover, Patient-activated event monitors may be more cost-effective than auto-detected monitors, particularly for patients with infrequent or intermittent symptoms.
"North American region accounted for the Second highest CAGR"
The global cardiac monitoring & cardiac rhythm management devices market is divided into four regions: North America, Asia-Pacific, Europe, and Rest of the World. According to the regional analysis, the North American region is likely to retain a considerable market share in 2023 and the future. The North American market is being propelled by an rising cases of heart diseases, rising in healthcare expenditure, rising in awareness about early disease diagnosis.
"Europe is estimated to register the third highest CAGR during the forecast period."
In this report, the cardiac monitoring & cardiac rhythm management devices market is segmented into four major regional segments: North America, Europe, Asia Pacific, Rest of the world. The market in Europe is projected to register the third highest growth rate during the forecast period. The growth in this market is due to Europe has a strong tradition of research and academic excellence, the rising incidence of aging population followed by cardiac diseases, government funding for research and healthcare in many European countries supports the development and adoption of advanced diagnostic technologies such as cardiac screening.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 32%, Tier 2 - 44%, and Tier 3 - 24%
- By Designation: C-level - 30%, D-level - 34%, and Others - 36%
- By Region: North America - 40%, Europe - 28%, Asia Pacific - 20%, and the Rest of the World - 12%
Lits of Companies Profiled in the Report:
- Abbott Laboratories (US)
- Medtronic (Ireland)
- Boston Scientific Corporation (US)
- GE HealthCare (US)
- Koninklijke Philips N.V. (Netherlands)
- Asahi Kasei Corporation. (Japan)
- MicroPort Scientific Corporatio (China)
- Baxter.(US)
- NIHON KOHDEN CORPORATION.(Japan)
- BIOTRONIK (Germany)
- SCHILLER (Switzerland)
- ACS Diagnostics.(US)
- BPL Medical Technologies (India)
- BTL (US)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.(China)
- OSYPKA AG (Germany)
- AliveCor, Inc.(US)
- Amiitalia (Italy)
- Bexen Cardio (Spain)
- Narang Medical Limited (India)
- Primedic (Germany)
- Progetti (Italy)
- INNOMED MEDICAL INC.(Hungary)
- LUMED srl (Italy)
- Nasiff Associates Inc. (US)
Research Coverage:
This report studies the cardiac monitoring & cardiac rhythm management devices market based on Type, Application, Procedure, End User, and Region. The report also analyses factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cardiac monitoring & cardiac rhythm management devices market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
Market Drivers: Comprehensive information about driving factors of the markets. The report analyses the markets drivers across key geographic regions.
Market Penetration: Comprehensive information on cardiac monitoring & cardiac rhythm management devices Market products offered by the top 25 players in the market. The report analyses the cardiac monitoring & cardiac rhythm management devices market by Product & Service, Type, Medical Condition, Technology, End User, and Region.
Market Development: Comprehensive information about lucrative emerging markets. The report analyses the markets for various securement devices across key geographic regions.
Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the cardiac monitoring & cardiac rhythm management devices market
Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cardiac monitoring & cardiac rhythm management devices market
Market Position: It will upkeep stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.
1 INTRODUCTION 48
1.1 STUDY OBJECTIVES 48
1.2 MARKET DEFINITION 48
1.2.1 INCLUSIONS & EXCLUSIONS 49
1.3 MARKET SCOPE 49
1.3.1 MARKETS COVERED 49
1.3.2 REGIONS COVERED 50
1.3.3 YEARS CONSIDERED 50
1.3.4 CURRENCY CONSIDERED 51
1.4 STAKEHOLDERS 51
1.5 SUMMARY OF CHANGES 51
1.5.1 RECESSION IMPACT 52
2 RESEARCH METHODOLOGY 53
2.1 RESEARCH DATA 53
2.2 RESEARCH APPROACH 53
FIGURE 1 RESEARCH DESIGN 53
2.2.1 SECONDARY DATA 54
2.2.1.1 Key data from secondary sources 55
2.2.2 PRIMARY DATA 55
FIGURE 2 PRIMARY SOURCES 56
2.2.2.1 Key data from primary sources 57
2.2.2.2 Key industry insights 57
2.2.2.3 Breakdown of primary interviews 58
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 58
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS 58
2.3 MARKET SIZE ESTIMATION 59
2.3.1 BOTTOM-UP APPROACH 59
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 59
2.3.2 GROWTH FORECAST 60
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 60
2.3.3 TOP-DOWN APPROACH 60
FIGURE 7 TOP-DOWN APPROACH 61
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 62
FIGURE 8 MARKET DATA TRIANGULATION METHODOLOGY 62
2.5 ASSUMPTIONS 63
FIGURE 9 ASSUMPTIONS FOR RESEARCH 63
2.6 LIMITATIONS 64
2.7 RISK ASSESSMENT 64
TABLE 1 RISK ASSESSMENT: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET 64
2.8 RECESSION IMPACT ANALYSIS 64
3 EXECUTIVE SUMMARY 65
FIGURE 10 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 65
FIGURE 11 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 66
FIGURE 12 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 66
FIGURE 13 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2024 VS. 2029 (USD MILLION) 67
FIGURE 14 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 67
FIGURE 15 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 68
4 PREMIUM INSIGHTS 69
4.1 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OVERVIEW 69
FIGURE 16 GROWING PREVALENCE OF GENETIC DISORDERS TO DRIVE MARKET 69
4.2 ECG DEVICES MARKET, BY TYPE, 2024-2029 70
FIGURE 17 RESTING ECG DEVICES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 70
4.3 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER (2024) 70
FIGURE 18 US AND INVASIVE PROCEDURES TO DOMINATE NORTH AMERICAN MARKET IN 2024 70
4.4 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 71
FIGURE 19 ASIAN COUNTRIES TO REGISTER HIGHER GROWTH FROM 2024 TO 2029 71
5 MARKET OVERVIEW 72
5.1 INTRODUCTION 72
5.2 MARKET DYNAMICS 72
FIGURE 20 CM & CRM DEVICES MARKET: DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 72
5.2.1 DRIVERS 73
5.2.1.1 Growing geriatric population and subsequent increase in CVD prevalence 73
FIGURE 21 HEART AND CIRCULATORY DISEASE PREVALENCE: GLOBAL STATISTICS (2021) 73
5.2.1.2 Availability of reimbursement for CM & CRM devices 74
TABLE 2 CPT CODES FOR CM & CRM DEVICES, 2020 74
5.2.1.3 Rising awareness and prevention initiatives 74
5.2.1.4 Increasing investments, funds, and grants for research 75
5.2.1.5 Growing preference for wearable cardiac devices 75
5.2.2 RESTRAINTS 76
5.2.2.1 High device costs 76
5.2.2.2 Adverse effects and associated complications 76
TABLE 3 POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT DEVICES 76
5.2.3 OPPORTUNITIES 77
5.2.3.1 Measures to reduce infections caused by CIEDs 77
5.2.3.2 Untapped emerging markets 77
5.2.4 CHALLENGES 78
5.2.4.1 Risk of associated cybersecurity vulnerabilities 78
5.2.4.2 Frequent product recalls 78
TABLE 4 KEY PRODUCT RECALLS 78
5.2.4.3 Stringent regulatory requirements delaying the approval of cardiac devices 78
5.2.4.4 Dearth of skilled professionals 79
5.3 PORTER'S FIVE FORCES ANALYSIS 79
TABLE 5 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS 79
5.3.1 THREAT OF NEW ENTRANTS 79
5.3.2 THREAT OF SUBSTITUTES 80
5.3.3 BARGAINING POWER OF BUYERS 80
5.3.4 BARGAINING POWER OF SUPPLIERS 80
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 80
5.4 ECOSYSTEM/MARKET MAP 80
FIGURE 22 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: ECOSYSTEM 80
TABLE 6 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET: ROLE IN ECOSYSTEM 81
FIGURE 23 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET: KEY PLAYERS 81
5.5 VALUE CHAIN ANALYSIS 82
FIGURE 24 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASE 82
5.6 SUPPLY CHAIN ANALYSIS 83
FIGURE 25 DIRECT DISTRIBUTION-PREFERRED STRATEGY FOR PROMINENT COMPANIES 83
5.7 REGULATORY LANDSCAPE 84
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
5.7.2 NORTH AMERICA 86
5.7.2.1 US 86
5.7.2.2 Canada 86
5.7.3 EUROPE 86
5.7.4 ASIA PACIFIC 86
5.7.4.1 China 86
5.7.4.2 Japan 87
5.7.4.3 India 87
5.7.5 LATIN AMERICA 87
5.7.5.1 Brazil 87
5.7.5.2 Mexico 88
5.7.6 MIDDLE EAST 88
5.7.7 AFRICA 88
5.8 PRICING ANALYSIS 89
5.8.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT 89
TABLE 12 AVERAGE SELLING PRICE OF HOLTER ECG MONITORS 89
TABLE 13 AVERAGE SELLING PRICE OF DEFIBRILLATORS 89
5.9 TRADE ANALYSIS 90
TABLE 14 IMPORT DATA FOR HS CODE 901819-COMPLIANT PRODUCTS, BY COUNTRY, 2018-2022 (USD MILLION) 90
TABLE 15 EXPORT DATA FOR HS CODE 901819-COMPLIANT PRODUCTS, BY COUNTRY, 2018-2022 (USD MILLION) 90
5.10 TECHNOLOGY ANALYSIS 91
5.10.1 HOLTER MONITOR 91
5.10.2 DEFIBRILLATORS 91
5.11 PATENT ANALYSIS 92
FIGURE 26 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: TOP 10 COMPANIES (APPLICATIONS/OWNERS) 92
5.12 KEY CONFERENCES AND EVENTS, 2024-2025 93
TABLE 16 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: LIST OF CONFERENCES AND EVENTS 93
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 94
FIGURE 27 REVENUE SHIFT IN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET 94
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 94
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 94
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS 94
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS (%) 95
5.14.2 BUYING CRITERIA 95
FIGURE 29 KEY BUYING CRITERIA FOR TOP TWO END USERS 95
TABLE 18 KEY BUYING CRITERIA FOR TOP TWO END USERS 95
6 CARDIAC MONITORING DEVICES MARKET, BY TYPE 96
6.1 INTRODUCTION 97
TABLE 19 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 97
6.2 ECG DEVICES 97
TABLE 20 ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 97
TABLE 21 ECG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 98
6.2.1 RESTING ECG DEVICES 98
6.2.1.1 Low cost, ease of use, and simplicity to drive adoption 98
TABLE 22 RESTING ECG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 98
6.2.2 STRESS ECG DEVICES 99
6.2.2.1 High device cost to affect adoption rate 99
TABLE 23 STRESS ECG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 99
6.2.3 HOLTER MONITORS 99
6.2.3.1 Short duration of monitoring to restrain adoption 99
TABLE 24 HOLTER MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION) 100
6.2.4 EVENT MONITORS 100
TABLE 25 EVENT MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION) 101
6.2.4.1 Event monitors market, by type 101
TABLE 26 EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 101
6.2.4.1.1 Loop memory monitors 101
6.2.4.1.1.1 Large storage capacity to support use in long-term monitoring 101
TABLE 27 LOOP MEMORY MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION) 102
6.2.4.1.2 Patch recorders 102
6.2.4.1.2.1 Patch recorders to play valuable role in diagnosing and managing cardiac conditions 102
TABLE 28 PATCH RECORDER EVENT MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION) 102
6.2.4.1.3 Symptom event monitors 103
6.2.4.1.3.1 Ease of use and on-demand recording to drive adoption 103
TABLE 29 SYMPTOM EVENT MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION) 103
6.2.4.1.4 Implanted loop recorders 103
6.2.4.1.4.1 High cost and limited applications to hinder demand growth 103
TABLE 30 IMPLANTED LOOP RECORDERS MARKET, BY REGION, 2022-2029 (USD MILLION) 104
6.2.4.2 Event monitors market, by technology 104
TABLE 31 EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 104
6.2.4.2.1 Patient-activated event monitors 104
6.2.4.2.1.1 Need for manual activation to slow market growth 104
TABLE 32 PATIENT-ACTIVATED EVENT MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION) 104
6.2.4.2.2 Auto-detect event monitors 105
6.2.4.2.2.1 Auto-detect monitors to show higher CAGR in event monitors segment 105
TABLE 33 AUTO-DETECT EVENT MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION) 105
6.2.5 SMART ECG MONITORS 105
6.2.5.1 Lack of data security to hinder market growth 105
TABLE 34 INDICATIVE LIST OF SMART ECG MONITORS 106
TABLE 35 SMART ECG MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION) 106
6.3 MCT DEVICES 107
6.3.1 INCREASING DEMAND FOR CARDIAC MONITORING SOLUTIONS IN HOME CARE SETTINGS TO PROPEL MARKET GROWTH 107
TABLE 36 MCT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 107
6.4 COM DEVICES 108
6.4.1 RISING NUMBER OF CARDIAC SURGERIES TO DRIVE DEMAND FOR COM DEVICES 108
TABLE 37 TYPES OF COM DEVICES 108
TABLE 38 COM DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 108
7 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE 109
7.1 INTRODUCTION 110
TABLE 39 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 110
TABLE 40 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2023-2029 (UNITS) 110
7.2 DEFIBRILLATORS 111
TABLE 41 DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 111
TABLE 42 DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION) 111
7.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 111
TABLE 43 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 112
TABLE 44 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION) 112
7.2.1.1 Transvenous ICDs 113
TABLE 45 TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 113
TABLE 46 TRANSVENOUS ICDS MARKET, BY REGION, 2022-2029 (USD MILLION) 113
7.2.1.1.1 Biventricular ICDS/CRT-Ds 114
7.2.1.1.1.1 Greater preference in heart failure patients to drive market 114
TABLE 47 BIVENTRICULAR ICDS/CRT-DS MARKET, BY REGION, 2022-2029 (USD MILLION) 114
7.2.1.1.2 Dual-chamber ICDs 114
7.2.1.1.2.1 Higher diagnostic accuracy to support usage 114
TABLE 48 DUAL-CHAMBER ICDS MARKET, BY REGION, 2022-2029 (USD MILLION) 115
7.2.1.1.3 Single-chamber ICDs 115
7.2.1.1.3.1 Launch of MRI-compatible single-chamber ICDs to support market growth 115
TABLE 49 SINGLE-CHAMBER ICDS MARKET, BY REGION, 2022-2029 (USD MILLION) 115
7.2.1.2 Subcutaneous ICDs 116
7.2.1.2.1 Safety and efficacy of S-ICDs to boost adoption 116
TABLE 50 SUBCUTANEOUS ICDS MARKET, BY REGION, 2022-2029 (USD MILLION) 116
7.2.2 EXTERNAL DEFIBRILLATORS 116
TABLE 51 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 117
TABLE 52 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION) 117
7.2.2.1 Automated external defibrillators 117
TABLE 53 INDICATIVE LIST OF AEDS THAT HAVE RECEIVED US FDA PRE-MARKET APPROVAL (2018-2022) 118
TABLE 54 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 118
TABLE 55 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION) 119
7.2.2.1.1 Semi-automated external defibrillators 119
7.2.2.1.1.1 Semi-automated external defibrillators to hold largest market share 119
TABLE 56 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION) 119
7.2.2.1.2 Fully automated external defibrillators 120
7.2.2.1.2.1 Benefits of fully automatic AEDs and higher accuracy to drive market 120
TABLE 57 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION) 120
7.2.2.2 Manual external defibrillators 120
7.2.2.2.1 North America to dominate manual defibrillators market 120
TABLE 58 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION) 121
7.2.2.3 Wearable cardioverter defibrillators 121
7.2.2.3.1 Ease of use and noninvasive nature to support market growth 121
TABLE 59 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION) 121
7.3 PACEMAKERS 122
TABLE 60 PACEMAKERS MARKET, BY REGION, 2022-2029 (USD MILLION) 122
7.3.1 PACEMAKERS MARKET, BY IMPLANTABILITY 122
TABLE 61 PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 122
7.3.1.1 Implantable pacemakers 122
7.3.1.1.1 Introduction of leadless and MRI-safe devices to boost adoption 122
TABLE 62 IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2022-2029 (USD MILLION) 123
7.3.1.2 External pacemakers 123
7.3.1.2.1 Increasing number of open-heart surgeries to drive demand 123
TABLE 63 EXTERNAL PACEMAKERS MARKET, BY REGION, 2022-2029 (USD MILLION) 124
7.3.2 PACEMAKERS MARKET, BY TYPE 124
TABLE 64 PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 124
7.3.2.1 Biventricular/CRT-Ps 124
7.3.2.1.1 High cost and unfavorable reimbursement to hinder growth 124
TABLE 65 BIVENTRICULAR/CRT-PS MARKET, BY REGION, 2022-2029 (USD MILLION) 125
7.3.2.2 Dual-chamber pacemakers 125
7.3.2.2.1 Dual-chamber pacemakers to witness high demand due to widespread usage 125
TABLE 66 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2022-2029 (USD MILLION) 125
7.3.2.3 Single-chamber pacemakers 125
7.3.2.3.1 Introduction of leadless pacemakers to stimulate demand 125
TABLE 67 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION, 2022-2029 (USD MILLION) 126
8 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE 127
8.1 INTRODUCTION 128
TABLE 68 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 128
8.2 INVASIVE PROCEDURES 128
8.2.1 GROWING NUMBER OF CARDIAC PROCEDURES TO DRIVE MARKET GROWTH 128
TABLE 69 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR INVASIVE PROCEDURES, BY REGION, 2022-2029 (USD MILLION) 129
8.3 NON-INVASIVE PROCEDURES 129
8.3.1 GROWING PREVALENCE OF LIFESTYLE AND GENETIC DISEASES TO PROPEL ADOPTION 129
TABLE 70 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR NON-INVASIVE PROCEDURES, BY REGION, 2022-2029 (USD MILLION) 129
9 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION 130
9.1 INTRODUCTION 131
TABLE 71 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 131
9.2 ARRHYTHMIAS 131
9.2.1 GROWING NUMBER OF ATRIAL FIBRILLATION CASES TO DRIVE MARKET 131
TABLE 72 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR ARRHYTHMIAS, BY REGION, 2022-2029 (USD MILLION) 132
9.3 MYOCARDIAL INFARCTION 132
9.3.1 RISING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH 132
TABLE 73 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR MYOCARDIAL INFARCTION, 2022-2029 (USD MILLION) 132
9.4 HEART FAILURE 133
9.4.1 GROWING AGING POPULATION TO DRIVE PREVALENCE OF HEART FAILURE 133
TABLE 74 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HEART FAILURE, BY REGION, 2022-2029 (USD MILLION) 133
9.5 OTHER APPLICATIONS 133
TABLE 75 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 134
10 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER 135
10.1 INTRODUCTION 136
TABLE 76 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 136
10.2 HOSPITALS 136
10.2.1 RISING NUMBER OF CARDIAC IMPLANT PROCEDURES TO DRIVE MARKET 136
TABLE 77 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2029 (USD MILLION) 137
10.3 CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS 137
10.3.1 GROWING FOCUS ON AMBULATORY CARE IN US TO PROPEL DEVICE ADOPTION 137
TABLE 78 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2022-2029 (USD MILLION) 138
10.4 OTHER END USERS 138
TABLE 79 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION) 138
11 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION 139
11.1 INTRODUCTION 140
TABLE 80 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 140
TABLE 81 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 140
TABLE 82 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 141
11.2 NORTH AMERICA 141
11.2.1 NORTH AMERICA: RECESSION IMPACT 141
FIGURE 30 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT 142
TABLE 83 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 142
TABLE 84 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 143
TABLE 85 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 143
TABLE 86 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 143
TABLE 87 NORTH AMERICA: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 144
TABLE 88 NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 144
TABLE 89 NORTH AMERICA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 144
TABLE 90 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 145
TABLE 91 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 145
TABLE 92 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 145
TABLE 93 NORTH AMERICA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 146
TABLE 94 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 146
TABLE 95 NORTH AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 146
TABLE 96 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 147
TABLE 97 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 147
TABLE 98 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 147
TABLE 99 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 148
TABLE 100 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 148
11.2.2 US 148
11.2.2.1 US to hold largest market share in North America 148
TABLE 101 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 149
TABLE 102 US: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 149
TABLE 103 US: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 149
TABLE 104 US: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 150
TABLE 105 US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 150
TABLE 106 US: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 150
TABLE 107 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 150
TABLE 108 US: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 151
TABLE 109 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 151
TABLE 110 US: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 151
TABLE 111 US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 152
TABLE 112 US: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 152
TABLE 113 US: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 152
TABLE 114 US: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 153
TABLE 115 US: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 153
11.2.3 CANADA 153
11.2.3.1 Growing funding for research to drive market 153
TABLE 116 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 154
TABLE 117 CANADA: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 154
TABLE 118 CANADA: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 155
TABLE 119 CANADA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 155
TABLE 120 CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 155
TABLE 121 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 156
TABLE 122 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 156
TABLE 123 CANADA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 156
TABLE 124 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 157
TABLE 125 CANADA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 157
TABLE 126 CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 157
TABLE 127 CANADA: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 158
TABLE 128 CANADA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 158
TABLE 129 CANADA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 158
TABLE 130 CANADA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 159
11.3 EUROPE 159
11.3.1 EUROPE: RECESSION IMPACT 159
TABLE 131 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 160
TABLE 132 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 160
TABLE 133 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 161
TABLE 134 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 161
TABLE 135 EUROPE: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 161
TABLE 136 EUROPE: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 162
TABLE 137 EUROPE: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 162
TABLE 138 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 162
TABLE 139 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 163
TABLE 140 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 163
TABLE 141 EUROPE: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 163
TABLE 142 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 164
TABLE 143 EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 164
TABLE 144 EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 164
TABLE 145 EUROPE: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 165
TABLE 146 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 165
TABLE 147 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 165
TABLE 148 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 166
11.3.2 GERMANY 166
11.3.2.1 Increasing healthcare expenditure to drive market growth 166
TABLE 149 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 166
TABLE 150 GERMANY: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 167
TABLE 151 GERMANY: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 167
TABLE 152 GERMANY: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 167
TABLE 153 GERMANY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 168
TABLE 154 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 168
TABLE 155 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 168
TABLE 156 GERMANY: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 169
TABLE 157 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 169
TABLE 158 GERMANY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 169
TABLE 159 GERMANY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 170
TABLE 160 GERMANY: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 170
TABLE 161 GERMANY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 170
TABLE 162 GERMANY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 171
TABLE 163 GERMANY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 171
11.3.3 FRANCE 171
11.3.3.1 Rising prevalence of heart failure to boost adoption of CRT devices 171
TABLE 164 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 172
TABLE 165 FRANCE: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 172
TABLE 166 FRANCE: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 172
TABLE 167 FRANCE: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 173
TABLE 168 FRANCE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 173
TABLE 169 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 173
TABLE 170 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 173
TABLE 171 FRANCE: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 174
TABLE 172 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 174
TABLE 173 FRANCE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 174
TABLE 174 FRANCE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 175
TABLE 175 FRANCE: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 175
TABLE 176 FRANCE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 175
TABLE 177 FRANCE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 176
TABLE 178 FRANCE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 176
11.3.4 UK 176
11.3.4.1 Rising demand for home-based cardiac monitoring devices to support market growth 176
TABLE 179 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 177
TABLE 180 UK: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 177
TABLE 181 UK: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 177
TABLE 182 UK: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 178
TABLE 183 UK: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 178
TABLE 184 UK: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 178
TABLE 185 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 178
TABLE 186 UK: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 179
TABLE 187 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 179
TABLE 188 UK: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 179
TABLE 189 UK: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 180
TABLE 190 UK: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 180
TABLE 191 UK: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 180
TABLE 192 UK: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 181
TABLE 193 UK: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 181
11.3.5 ITALY 181
11.3.5.1 Increasing incidence of atrial fibrillation to drive market 181
TABLE 194 ITALY: NUMBER OF ELDERLY CITIZENS WITH ATRIAL FIBRILLATION (THOUSANDS) 182
TABLE 195 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 196 ITALY: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 197 ITALY: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 183
TABLE 198 ITALY: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 183
TABLE 199 ITALY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 183
TABLE 200 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 184
TABLE 201 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 184
TABLE 202 ITALY: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 184
TABLE 203 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 185
TABLE 204 ITALY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 185
TABLE 205 ITALY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 185
TABLE 206 ITALY: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 186
TABLE 207 ITALY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 186
TABLE 208 ITALY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 186
TABLE 209 ITALY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 187
11.3.6 SPAIN 187
11.3.6.1 Rising awareness and growing device adoption to support market growth 187
TABLE 210 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 187
TABLE 211 SPAIN: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 188
TABLE 212 SPAIN: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 188
TABLE 213 SPAIN: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 188
TABLE 214 SPAIN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 215 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 216 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 217 SPAIN: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 190
TABLE 218 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 190
TABLE 219 SPAIN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 190
TABLE 220 SPAIN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 191
TABLE 221 SPAIN: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 191
TABLE 222 SPAIN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 191
TABLE 223 SPAIN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 192
TABLE 224 SPAIN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 192
11.3.7 REST OF EUROPE 192
TABLE 225 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2029 VS. 2050 193
TABLE 226 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 227 REST OF EUROPE: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 228 REST OF EUROPE: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 229 REST OF EUROPE: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 194
TABLE 230 REST OF EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 231 REST OF EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 232 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 233 REST OF EUROPE: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 234 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 196
TABLE 235 REST OF EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 196
TABLE 236 REST OF EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 196
TABLE 237 REST OF EUROPE: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 197
TABLE 238 REST OF EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 197
TABLE 239 REST OF EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 197
TABLE 240 REST OF EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 198
11.4 ASIA PACIFIC 198
11.4.1 ASIA PACIFIC: RECESSION IMPACT 198
FIGURE 31 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT 199
TABLE 241 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 200
TABLE 242 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 200
TABLE 243 ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 200
TABLE 244 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 245 ASIA PACIFIC: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 246 ASIA PACIFIC: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 247 ASIA PACIFIC: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 202
TABLE 248 ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 249 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 250 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 251 ASIA PACIFIC: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 203
TABLE 252 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 203
TABLE 253 ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 203
TABLE 254 ASIA PACIFIC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 204
TABLE 255 ASIA PACIFIC: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 204
TABLE 256 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 204
TABLE 257 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 205
TABLE 258 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 205
11.4.2 JAPAN 205
11.4.2.1 High healthcare expenditure and favorable reimbursement & insurance policies to support market growth 205
TABLE 259 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 260 JAPAN: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 261 JAPAN: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 262 JAPAN: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 207
TABLE 263 JAPAN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 264 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 265 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 266 JAPAN: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 208
TABLE 267 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 208
TABLE 268 JAPAN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 208
TABLE 269 JAPAN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 209
TABLE 270 JAPAN: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 209
TABLE 271 JAPAN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 209
TABLE 272 JAPAN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 210
TABLE 273 JAPAN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 210
11.4.3 CHINA 210
11.4.3.1 Rising prevalence of CVDs and government support for infrastructural improvement to drive market 210
TABLE 274 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 211
TABLE 275 CHINA: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 211
TABLE 276 CHINA: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 211
TABLE 277 CHINA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 212
TABLE 278 CHINA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 279 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 280 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 281 CHINA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 282 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 283 CHINA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 284 CHINA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 214
TABLE 285 CHINA: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 214
TABLE 286 CHINA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 214
TABLE 287 CHINA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 215
TABLE 288 CHINA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 215
11.4.4 INDIA 215
11.4.4.1 Increasing incidence of CVD to propel market growth 215
TABLE 289 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 290 INDIA: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 291 INDIA: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 292 INDIA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 217
TABLE 293 INDIA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 294 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 295 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 296 INDIA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 218
TABLE 297 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 218
TABLE 298 INDIA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 218
TABLE 299 INDIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 219
TABLE 300 INDIA: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 219
TABLE 301 INDIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 219
TABLE 302 INDIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 220
TABLE 303 INDIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 220
11.4.5 REST OF ASIA PACIFIC 220
TABLE 304 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 221
TABLE 305 REST OF ASIA PACIFIC: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 221
TABLE 306 REST OF ASIA PACIFIC: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 222
TABLE 307 REST OF ASIA PACIFIC: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 222
TABLE 308 REST OF ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 222
TABLE 309 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 223
TABLE 310 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 223
TABLE 311 REST OF ASIA PACIFIC: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 223
TABLE 312 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 224
TABLE 313 REST OF ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 224
TABLE 314 REST OF ASIA PACIFIC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 224
TABLE 315 REST OF ASIA PACIFIC: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 225
TABLE 316 REST OF ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 225
TABLE 317 REST OF ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 225
TABLE 318 REST OF ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 226
11.5 REST OF THE WORLD 226
11.5.1 REST OF THE WORLD: RECESSION IMPACT 226
TABLE 319 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 226
TABLE 320 REST OF THE WORLD: CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 227
TABLE 321 REST OF THE WORLD: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 227
TABLE 322 REST OF THE WORLD: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 227
TABLE 323 REST OF THE WORLD: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 324 REST OF THE WORLD: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 325 REST OF THE WORLD: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 228
TABLE 326 REST OF THE WORLD: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 229
TABLE 327 REST OF THE WORLD: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 229
TABLE 328 REST OF THE WORLD: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 229
TABLE 329 REST OF THE WORLD: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 230
TABLE 330 REST OF THE WORLD: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 230
TABLE 331 REST OF THE WORLD: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 230
TABLE 332 REST OF THE WORLD: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 231
TABLE 333 REST OF THE WORLD: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 231
TABLE 334 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 231
TABLE 335 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 232
TABLE 336 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 232
11.5.2 LATIN AMERICA 232
11.5.2.1 Rising patient population and growing disease incidence to support market growth 232
TABLE 337 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 233
TABLE 338 LATIN AMERICA: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 233
TABLE 339 LATIN AMERICA: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 233
TABLE 340 LATIN AMERICA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 234
TABLE 341 LATIN AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 234
TABLE 342 LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 234
TABLE 343 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 235
TABLE 344 LATIN AMERICA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 235
TABLE 345 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 235
TABLE 346 LATIN AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 236
TABLE 347 LATIN AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 236
TABLE 348 LATIN AMERICA: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 236
TABLE 349 LATIN AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 237
TABLE 350 LATIN AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 237
TABLE 351 LATIN AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 237
11.5.3 MIDDLE EAST & AFRICA 238
11.5.3.1 Prominence of local players and healthcare infrastructural improvements to support growth 238
TABLE 352 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 238
TABLE 353 MIDDLE EAST & AFRICA: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 238
TABLE 354 MIDDLE EAST & AFRICA: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 239
TABLE 355 MIDDLE EAST & AFRICA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 239
TABLE 356 MIDDLE EAST & AFRICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 239
TABLE 357 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 240
TABLE 358 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 240
TABLE 359 MIDDLE EAST & AFRICA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 240
TABLE 360 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 241
TABLE 361 MIDDLE EAST & AFRICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 241
TABLE 362 MIDDLE EAST & AFRICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 241
TABLE 363 MIDDLE EAST & AFRICA: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 242
TABLE 364 MIDDLE EAST & AFRICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 242
TABLE 365 MIDDLE EAST & AFRICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 242
TABLE 366 MIDDLE EAST & AFRICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 243
11.5.4 GCC COUNTRIES 243
11.5.4.1 Increasing awareness and government initiatives to favor market growth 243
TABLE 367 GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 243
TABLE 368 GCC COUNTRIES: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 244
TABLE 369 GCC COUNTRIES: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 244
TABLE 370 GCC COUNTRIES: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 244
TABLE 371 GCC COUNTRIES: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 245
TABLE 372 GCC COUNTRIES: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 245
TABLE 373 GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 245
TABLE 374 GCC COUNTRIES: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 375 GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 376 GCC COUNTRIES: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 377 GCC COUNTRIES: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION) 247
TABLE 378 GCC COUNTRIES: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 247
TABLE 379 GCC COUNTRIES: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 247
TABLE 380 GCC COUNTRIES: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 248
TABLE 381 GCC COUNTRIES: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 248
12 COMPETITIVE LANDSCAPE 249
12.1 OVERVIEW 249
12.2 KEY STRATEGIES/RIGHT TO WIN 249
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 249
TABLE 382 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CARDIAC MONITORING DEVICES & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET 249
12.3 MARKET SHARE ANALYSIS 251
TABLE 383 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: DEGREE OF COMPETITION 251
12.4 REVENUE SHARE ANALYSIS 252
FIGURE 32 REVENUE SHARE ANALYSIS OF KEY PLAYERS 252
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 253
12.5.1 STARS 253
12.5.2 EMERGING LEADERS 253
12.5.3 PERVASIVE PLAYERS 253
12.5.4 PARTICIPANTS 253
FIGURE 33 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 254
12.5.5 COMPANY FOOTPRINT 255
FIGURE 34 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: COMPANY FOOTPRINT 255
TABLE 384 COMPANY FOOTPRINT 255
TABLE 385 PRODUCT FOOTPRINT 256
TABLE 386 REGIONAL FOOTPRINT 257
12.6 COMPANY EVALUATION MATRIX: START-UP/SME PLAYERS 258
12.6.1 PROGRESSIVE COMPANIES 258
12.6.2 RESPONSIVE COMPANIES 258
12.6.3 DYNAMIC COMPANIES 258
12.6.4 STARTING BLOCKS 258
FIGURE 35 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (START-UP/SME PLAYERS), 2023 259
12.6.5 COMPETITIVE BENCHMARKING 260
TABLE 387 DETAILED LIST OF KEY START-UPS/SMES IN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET 260
12.7 VALUATION AND FINANCIAL METRICS OF CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICE VENDORS 260
FIGURE 36 EV/EBITDA OF KEY VENDORS 260
FIGURE 37 EV/REV OF KEY VENDORS 261
FIGURE 38 BETA (5 YEARS) OF KEY VENDORS 261
FIGURE 39 1-YEAR PRICE TOTAL RETURN OF KEY VENDORS 262
12.8 COMPETITIVE SCENARIO 262
12.8.1 PRODUCT LAUNCHES & APPROVALS 262
TABLE 388 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-APRIL 2024 262
12.8.2 DEALS 263
TABLE 389 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: DEALS, JANUARY 2021-APRIL 2024 263
12.9 BRAND/PRODUCT COMPARISON 263
13 COMPANY PROFILES 264
13.1 KEY PLAYERS 264
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 ABBOTT LABORATORIES 264
TABLE 390 ABBOTT LABORATORIES: COMPANY OVERVIEW 264
FIGURE 40 ABBOTT LABORATORIES: COMPANY SNAPSHOT 265
TABLE 391 ABBOTT LABORATORIES: PRODUCTS OFFERED 265
TABLE 392 ABBOTT LABORATORIES: PRODUCT LAUNCHES (JANUARY 2021-APRIL 2024) 266
13.1.2 MEDTRONIC 267
TABLE 393 MEDTRONIC: COMPANY OVERVIEW 267
FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT 268
TABLE 394 MEDTRONIC: PRODUCTS OFFERED 268
13.1.3 BOSTON SCIENTIFIC CORPORATION 271
TABLE 395 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 271
FIGURE 42 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 272
TABLE 396 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 272
TABLE 397 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS (JANUARY 2021-APRIL 2024) 274
13.1.4 GE HEALTHCARE 275
TABLE 398 GE HEALTHCARE: COMPANY OVERVIEW 275
FIGURE 43 GE HEALTHCARE: COMPANY SNAPSHOT 276
TABLE 399 GE HEALTHCARE: PRODUCTS OFFERED 276
13.1.5 KONINKLIJKE PHILIPS N.V. 277
TABLE 400 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 277
FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 278
TABLE 401 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 278
TABLE 402 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES (JANUARY 2021-APRIL 2024) 279
13.1.6 ASAHI KASEI CORPORATION 280
TABLE 403 ASAHI KASEI CORPORATION: COMPANY OVERVIEW 280
FIGURE 45 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT 281
TABLE 404 ASAHI KASEI CORPORATION: PRODUCTS OFFERED 281
13.1.7 MICROPORT SCIENTIFIC CORPORATION 282
TABLE 405 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 282
FIGURE 46 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 283
TABLE 406 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 284
13.1.8 BAXTER 285
TABLE 407 BAXTER: COMPANY OVERVIEW 285
FIGURE 47 BAXTER: COMPANY SNAPSHOT 286
TABLE 408 BAXTER: PRODUCTS OFFERED 286
TABLE 409 BAXTER: DEALS (JANUARY 2021-APRIL 2024) 287
13.1.9 NIHON KOHDEN CORPORATION 288
TABLE 410 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 288
FIGURE 48 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 288
TABLE 411 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 289
TABLE 412 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES (JANUARY 2021-APRIL 2024) 289
13.1.10 BIOTRONIK 290
TABLE 413 BIOTRONIK: COMPANY OVERVIEW 290
TABLE 414 BIOTRONIK: PRODUCTS OFFERED 290
13.1.11 SCHILLER 292
TABLE 415 SCHILLER: COMPANY OVERVIEW 292
TABLE 416 SCHILLER: PRODUCTS OFFERED 292
13.1.12 ACS DIAGNOSTICS 293
TABLE 417 ACS DIAGNOSTICS: COMPANY OVERVIEW 293
TABLE 418 ACS DIAGNOSTICS: PRODUCTS OFFERED 293
13.1.13 BPL MEDICAL TECHNOLOGIES 294
TABLE 419 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW 294
TABLE 420 BPL MEDICAL TECHNOLOGIES: PRODUCTS OFFERED 294
13.1.14 BTL 296
TABLE 421 BTL: COMPANY OVERVIEW 296
TABLE 422 BTL: PRODUCTS OFFERED 296
13.1.15 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 297
TABLE 423 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
COMPANY OVERVIEW 297
TABLE 424 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
PRODUCTS OFFERED 297
13.2 OTHER PLAYERS 298
13.2.1 OSYPKA AG 298
13.2.2 ALIVECOR, INC. 298
13.2.3 AMIITALIA 299
13.2.4 BEXEN CARDIO 299
13.2.5 NARANG MEDICAL LIMITED 300
13.2.6 PRIMEDIC 300
13.2.7 PROGETTI 300
13.2.8 INNOMED MEDICAL INC. 301
13.2.9 LUMED SRL 301
13.2.10 NASIFF ASSOCIATES INC. 302
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 303
14.1 DISCUSSION GUIDE 303
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 309
14.3 CUSTOMIZATION OPTIONS 311
14.4 RELATED REPORTS 312
14.5 AUTHOR DETAILS 313
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security